National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials
Clinical Journal of the American Society of Nephrology · 2026-11 · 21 (11) · 2041-2050
DOI: 10.2215/cjn.0000001031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 17.02.2026. Verfasst von Melanie S Joy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Diseases and Hypertension, Skaggs School of Pharmacy, School of Medicine, University of Colorado, Aurora, Colorado. Hauptthemen laut MEDLINE: Precision Medicine, Clinical Trials as Topic, Kidney Diseases, Nephrology. Die Arbeit nennt 65 Literaturangaben.
Abstract (Originalsprache)
The National Institute of Diabetes and Digestive and Kidney Diseases sponsored a scientific workshop in 2024, titled “Preparing for Kidney Precision Medicine Clinical Trials.” The purpose of the workshop was to gain a better understanding of the therapeutic journey of patients with kidney disease and define candidate indicators for precision medicine strategies, targets, and trial readiness. Workshop participants were tasked with identifying best practices, opportunities, and barriers to kidney precision medicine clinical trials, with a shared goal to optimize the design and conduct of these trials. The patient perspective served as a foundation for the meeting. Trial design should be flexible, dynamic, responsive to transitions in patient care and minimize fragmentation of care. The value of understanding mechanisms and defining endophenotypes and targets to facilitate new therapeutic approaches was discussed with examples presented for acute and CKDs. The importance of biomarkers for diagnosis and evaluation of therapeutic response was emphasized. Laboratory and assay considerations for precision medicine trials were discussed with examples of successful large precision medicine trials supported by laboratory networks presented. There was discussion of the barriers to precision trials in nephrology, including suboptimal patient engagement, precision trial expertise, infrastructure, and financial resources. Engagement in demonstration projects to test the ability of various approaches to expedite the right treatment to the right patient was highlighted. Of utmost importance is the better design of clinical trials which consider differences in genetics and status of disease mechanisms to validate individual patient-focused innovative and effective precision therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Renal Diseases and Hypertension, Skaggs School of Pharmacy, School of Medicine, University of Colorado, Aurora, Colorado.
- Division of Nephrology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
- American Association of Kidney Patients, Falls Church, Virginia.
- Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Stanford, California.
- Medicine and Anesthesia, University of California, San Francisco, San Francisco, California.
- Kidney Health Initiative, American Society of Nephrology, Washington, DC.
ORCID-Profile: Rasheed A Gbadegesin, Paul T Conway, Glenn M Chertow, Mark D Lim, Matthias Kretzler
Zitieren
APA
Joy, M. S., Gbadegesin, R. A., Conway, P. T., Chertow, G. M., Liu, K. D., Lim, M. D., Kretzler, M., Bonventre, J. V., & Precision Medicine Workshop Speakers and Moderators (2026). National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials. Clinical Journal of the American Society of Nephrology, 21(11), 2041-2050. https://doi.org/10.2215/cjn.0000001031
Vancouver
Joy MS, Gbadegesin RA, Conway PT, Chertow GM, Liu KD, Lim MD, et al. National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials. Clinical Journal of the American Society of Nephrology. 2026;21(11):2041-2050. doi:10.2215/cjn.0000001031
BibTeX
@article{Joy2026,
author = {Joy, Melanie S and Gbadegesin, Rasheed A and Conway, Paul T and Chertow, Glenn M and Liu, Kathleen D and Lim, Mark D and Kretzler, Matthias and Bonventre, Joseph V and Precision Medicine Workshop Speakers and Moderators, Precision Medicine Workshop Speakers and Moderators},
title = {National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {11},
pages = {2041--2050},
doi = {10.2215/cjn.0000001031}
}
EUVIMED